Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children

scientific article

Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PNTD.0005014
P3181OpenCitations bibliographic resource ID3323737
P932PMC publication ID5038947
P698PubMed publication ID27677183

P50authorIvo MuellerQ60043791
Peter M SibaQ89223280
Camila FrançaQ42804090
Wai-Hong ThamQ43156755
P2093author name stringBenson Kiniboro
Enmoore Lin
Nicholas T Y Lim
Wen-Qiang He
Jakub Gruszczyk
P2860cites workMultiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatantsQ64128890
The cellular and molecular basis for malaria parasite invasion of the human red blood cellQ21032502
Comparative genomics of the neglected human malaria parasite Plasmodium vivaxQ22122202
Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodiesQ24289322
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparumQ24297064
Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptorQ24305554
Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy peopleQ24600330
Plasmodium falciparum Adhesins Play an Essential Role in Signalling and Activation of Invasion into Human ErythrocytesQ27316537
Revealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytesQ27321307
Genetic diversity in new members of the reticulocyte binding protein family in Thai Plasmodium vivax isolatesQ28731528
Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligandQ30043671
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malariaQ31169310
Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responsesQ33333604
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean childrenQ33530114
High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malariaQ34003525
Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivaxQ34091277
Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysisQ34234390
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibodyQ34241973
Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malariaQ34301187
IgG subclasses and allotypes: from structure to effector functionsQ34368678
Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malariaQ34515219
Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models.Q34774347
Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigensQ34778078
Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseQ34955461
A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeysQ34978590
A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean childrenQ34990680
De novo assembly of a field isolate genome reveals novel Plasmodium vivax erythrocyte invasion genesQ35068049
Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of KenyaQ35101169
Crystal structure of PfRh5, an essential P. falciparum ligand for invasion of human erythrocytesQ35167000
An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical ProtectionQ36018397
Identification of Immunodominant B-cell Epitope Regions of Reticulocyte Binding Proteins in Plasmodium vivax by Protein Microarray Based ImmunoscreeningQ36050856
Recent advances in recombinant protein-based malaria vaccinesQ36394182
Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagementQ36483323
A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variantsQ36511421
Gene Models, Expression Repertoire, and Immune Response of Plasmodium vivax Reticulocyte Binding ProteinsQ36631336
Specific phosphorylation of the PfRh2b invasion ligand of Plasmodium falciparumQ36900517
Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean childrenQ37308698
Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.Q37412559
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasiteQ37583147
Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparumQ37969486
Dramatic difference in diversity between Plasmodium falciparum and Plasmodium vivax reticulocyte binding-like genes.Q38324751
Development of vaccines for Plasmodium vivax malariaQ38597276
Insights into the naturally acquired immune response to Plasmodium vivax malariaQ38728598
Plasmodium vivax malaria in Duffy-negative individuals from EthiopiaQ45728740
A reticulocyte-binding protein complex of plasmodium vivax merozoitesQ47860897
Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey.Q47867188
Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemiaQ47954510
Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malariaQ47957417
Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.Q48013929
The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys.Q48037292
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectPlasmodium vivaxQ311376
infectious diseaseQ18123741
P304page(s)e0005014
P577publication date2016-09-01
P1433published inPLoS Neglected Tropical DiseasesQ3359737
P1476titlePlasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children
P478volume10

Reverse relations

cites work (P2860)
Q28585693A new Plasmodium vivax reference sequence with improved assembly of the subtelomeres reveals an abundance of pir genes
Q91735070Analysis of serological data to investigate heterogeneity of malaria transmission: a community-based cross-sectional study in an area conducting elimination in Indonesia
Q92697512Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand
Q64237708Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria
Q61805875Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure
Q33617694Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand
Q33707030Characterising PvRBSA: an exclusive protein from Plasmodium species infecting reticulocytes
Q94671911Development and validation of serological markers for detecting recent Plasmodium vivax infection
Q90179089Humoral immunity prevents clinical malaria during Plasmodium relapses without eliminating gametocytes
Q54217362Identification and immunological characterization of the ligand domain of Plasmodium vivax reticulocyte binding protein 1a.
Q41994105Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development
Q90243753Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers
Q58571278Molecular and cellular interactions defining the tropism of Plasmodium vivax for reticulocytes
Q33834779Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria
Q38853118Naturally Acquired Human Antibodies Against Reticulocyte-Binding Domains of Plasmodium vivax Proteins, PvRBP2c and PvRBP1a, Exhibit Binding-Inhibitory Activity
Q54257609Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation?
Q93012608Plasmodium vivax Reticulocyte Binding Proteins for invasion into reticulocytes
Q56358317Plasmodium vivax in vitro continuous culture: the spoke in the wheel
Q41566130Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes.
Q42254570PvGAMA reticulocyte binding activity: predicting conserved functional regions by natural selection analysis
Q89968278Study protocol for a cluster-randomized split-plot design trial to assess the effectiveness of targeted active malaria case detection among high-risk populations in Southern Lao PDR (the AcME-Lao study)
Q89516787The Blood Stage Antigen RBP2-P1 of Plasmodium vivax Binds Reticulocytes and Is a Target of Naturally Acquired Immunity
Q89802320The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals
Q47208042Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax.
Q37638131What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?

Search more.